← All stocks

Merck & Co.

MRK Net selling
CIK 0000310158 #311 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$72.01M
$0.00 on a plan · $42.61M straight out of an exercise
Sold at will
$29.41M
20 of 35 sales
Net
−$72.01M
−$29.41M against sales at will

By person

16 insiders · 50 transactions
36.9×

Robert M. Davis holds 36.9 times base salary in stock. $60.80M of shares against $1.65M in salary for 2025.

Salary from the company's own proxy. The shares are what Robert M. Davis last reported holding, valued at $135.00, the price Common Stock was last bought or sold at on the open market here, on 13 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Zachary Jennifer
EVP, General Counsel
$25.20M (4) scheduled
−$25.20M
45,509
0.0018%
$6.14M
+40.5%
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
$11.29M (9)
−$11.29M
110,167
0.0045%
$14.87M
−31.3%
Guindo Chirfi
EVP, Access, Policy & Comms
$8.15M (5)
−$8.15M
36,613
0.0015%
$4.94M
−16.5%
Williams David Michael
EVP,Chief Info&Digital Officer
$8.13M (5) scheduled
−$8.13M
31,716
0.0013%
$4.28M
+54.1%
Davis Robert M
Chairman, CEO & President
$5.60M (2)
−$5.60M
450,351
0.0183%
$60.80M
+29.3%
Litchfield Caroline
EVP & CFO
$5.02M (1) scheduled
−$5.02M
92,301
0.0037%
$12.46M
+80.9%
Li Dean Y
Executive VP & President, MRL
$2.99M (2) scheduled
−$2.99M
94,431
0.0038%
$12.75M
+92.0%
Maraldo David R.
EVP & Pres. MMD
$2.41M (3) scheduled
−$2.41M
18,212
0.0007%
$2.46M
+2.2%
Oosthuizen Johannes Jacobus
EVP, Oncology & Int?l
$1.83M (1)
−$1.83M
21,895
0.0009%
$2.96M
−10.3%
Smart Dalton E. III
SVP Fin. - Global Controller
$765.92K (2) scheduled
−$765.92K
9,388
0.0004%
$1.27M
+110.4%
Downing Cristal N
Chief Comm. & Public Afrs Ofcr
$616.40K (1)
−$616.40K
0
0.0000%
$0.00
Romanelli Joseph
President, Human Health Int?l
28,739
0.0012%
$3.88M
+37.9%
BAKER DOUGLAS M JR
Director
16,000
0.0006%
$2.16M
+1,500%
Chattopadhyay Sanat
Exe V-P & Pres. MMD
15,347
0.0006%
$2.07M
Larson Betty D
EVP, Chief HR Officer
13,774
0.0006%
$1.86M
THULIN INGE G
Director
2,933
0.0001%
$395.94K
+2,833%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 15
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 537,512
History held since 1 Sep 2016